Infliximab-induced SLE-like syndrome involving the lung and pleura.
Diri
E
E
Tello
W
W
Ratnoff
W D
WD
Nugent
K
K
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D000069285:Infliximab; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D010994:Pleura / Q000187:drug effects / Q000473:pathology; D013577:Syndrome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab